Considering rescue strategy simulations, the combination of autologous anti-inflammatory serum containing TGF-β, GDF5, IL-10, and IL-4 emerges as compelling potential biological treatment for IDD. This evidence concerns the gene GDF5 and intervertebral disk degenerative disorder.